Find the latest news headlines from Illumina, Inc. Common Stock (ILMN) at Nasdaq.com. Phone: + 1704 266 3234 | +91-750-707-8687, DNA Next Generation Sequencing Market Research and Forecast 2019 to 2025 | Illumina, Roche, Pacific Biosciences, BGI, Thermo Fisher, DNA Next Generation Sequencing Market 2019, DNA Next Generation Sequencing Market Forecast, DNA Next Generation Sequencing market reports, DNA Next Generation Sequencing Market Research, DNA Next Generation Sequencing Market Study, DNA Next Generation Sequencing market Trends, Light Power Meters Market to Generate Huge Revenue in Industry by 2023, Business Headsets Market Report, History and Forecast 2019-2026, Breakdown Data by Manufacturers, Key Regions, Types and Application, Meal Replacement Shakes Market: Scope, Applications and Growth Framework 2018 – 2028, Drying Cabinets Market 2019 Revenue, Industry Growing Demand, Size, Share, Business Opportunities, Top Companies, Regional Outlook till 2026, Plastic Mulch Unrollers Market Growth Sales Revenue Analysis 2019-2028, Truck Bias Tire Market to Witness Widespread Expansion During 2021-2030, Automotive Seals and Gaskets Market Report 2021 Future Innovation Strategies and Top Competitors are: NOK, Federal-mogul, Freudenberg, Elringklinger, Dana, UK to Prepare Adequately for Cold Season with renewable Energy Plans, RSPB cautions of the fresh wind farm harm, The signing of the renewable energy agreement by UAE and Israel, The public participates in drafting the Law on renewable energy in Serbia, Pleasanton council has authenticated the pursuit of renewable energy options, Renewable Energy Hub announces the first transaction for Virtual Storage, Many welcome the US re-entry into the Paris Agreement, More investments in renewable energy by Southeast Asia’s governments, New Merger in Renewables to Hold Hope for Wind Based Energy Generation, The executive of the space sector advocates on Biden to retain the National Space Council, In the latest Starlink mission, SpaceX crosses the 1,000 satellite mark, Canada has secured a two-year grace period from the International Renewable Energy Agency Council, Conventional Energy Producers Shifting Towards Renewables in Poland, Canon allows its customers to take photos from the actual satellite, EIB has appropriated €200 million to Eutelsat for the deployment of satellites, European Space Agency and European Union fix their relations, French startups illustrate iodine propulsion as a possible aid to reduce space debris efforts, GE Renewable Energy in the last stages of processing the US offshore wind energy project deal, Tumor Markers Immunoassay Market Global Research and Clinical Survey 2019 to 2025 | Clarity Diagnostics LLC, CTK Biotech Inc, DIALAB GmbH, Tinea Pedis Treatment- Global Market Outlook 2019 to 2026 | GSK, Exeltis USA, Promius Pharma, Valeant, Incyte, Polichem, Biopharmaceutical Logistic Market to 2026 Business Opportunities and Future Analysis- UPS (Marken), DB Schenker, XPO Logistics, Panalpina, Electronic Cigarette Lithium Battery Market to Witness Steady Growth through 2019-2026 | Samsung, Sony, Panasonic, LG, EVE Energy, AWT, Polymer Microspheres Market Size, Status and Estimation 2019 to 2026 | Polysciences, Advanced Polymers, Bangs Laboratories, Cyclic Trimethylolpropane Formal (CTF) Market Strategy Report 2019 Forecast to 2026 | Club Car, Polaris, Ligier Professional, E-Z-GO, Alke. Today, shares run at about $383 each. Ion semi-conductor sequencing method is used in DNA sequencing for detection of hydrogen ions. To use TeamViewer, you need to perform a one-time download of TeamViewer Quick Support (Linux, Mac, or Windows). Request for sample copy of market report @: https://www.marketinsightsreports.com/reports/02061082327/global-dna-next-generation-sequencing-market-size-status-and-forecast-2019-2025/inquiry?Source=Bnews&mode=10. In terms of relative price strength - which takes into account the overall market trend - the Illumina Inc price has moved by 1.29% over the past year. Today, shares run at about $383 each. ILLUMINA Chart - ein übersichtlicher, großer Chart der ILLUMINA Aktie. Stiff Competition: Illumina faces tough competition from several biggies already enjoying significant market share, intellectual property portfolios and favorable regulatory developments. Get discount at (New Year exclusive offer up-to 30%): https://www.marketinsightsreports.com/reports/02061082327/global-dna-next-generation-sequencing-market-size-status-and-forecast-2019-2025/discount?Source=Bnews&mode=10. On … View and export this data going back to 2000. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California. Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. Chapter Three: Global Market Competition, by Players, Chapter Four: Global Market Size by Regions, Chapter Ten: Global DNA Next Generation Sequencing Market Segment by Type, Application. GAAP net income attributable to Illumina stockholders for the quarter of $47 million, or $0.32 per diluted share, compared to $296 million, or $1.99 per diluted share, for the second quarter of 2019 The growth of the DNA next generation sequencing market is attributed to the declining prices of sequencing services as well as various technological advancements in the field of sequencing during the recent years. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California. Using TeamViewer. *Before your trial expires, we’ll put together a custom quote with your long-term premium options. Never miss another important industry story. GenomeWeb Premium gives you: ✔ Full site access ✔ Interest-based email alerts ✔ Access to archives MarketInsightsReports provides global and Chinese and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations. According to the global market report, it will continue to rule in upcoming years. The all-time high Illumina stock closing price was 403.54 on January 20, 2021. Find the latest news headlines from Illumina, Inc. Common Stock (ILMN) at Nasdaq.com. In Sequence Survey: Illumina Holds Two-Thirds of Sequencing Market, Splits Desktop Share with Ion PGM, Microba, University of Queensland Partner to Study Gut Microbiome in Parkinson's Disease, In Brief This Week: Myriad Genetics, Guardant Health, Twist Bioscience, and More, People in the News: New Appointments at Foundation Medicine, Sophia Genetics, Circulogene; More, Predictive Oncology Announces $4.1M Direct Offering, Oppenheimer Initiates Coverage of DermTech With Outperform Rating, Invitae Prices $400M Common Stock Offering, Science Papers Trace Drivers of Metastasis; Genetic Analysis of Stone, Bronze Age Eastern Europeans, The Great Unknown of DNA Sequencing Variants: What You Need to Know, Compatibility of Liquid Biopsy Assays on Multiple Sequencing Platforms, The Challenges of Sequencing HBA1/2 Genes for Alpha-Thalassemia Research: A GenomeWeb eCase Study Transcript, Trends in Variant Interpretation Workflows: Expert Insights to Advance NGS Oncology Profiling, Case Study: Rapid Development and Manufacturing Scaleup of a Point-of-Care COVID-19 Test, Caris Shares Data for AI-Driven Tumor Origin Prediction, Hinting at Diagnostic, Patient Benefit. *A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: Obtains access to the information in a personal capacity; The survey, conducted in collaboration with investment firm Mizuho Securities, found that Illumina's HiSeq 2000, GA IIx, and MiSeq … You may find more results for this query on our sister sites: 360Dx and Precision Oncology News. The market is estimated to grow with a CAGR of 21.7% from 2018-2025. Illumina Shares Outstanding: 146.00M for Oct. 23, 2020. Illumina Reports Financial Results for First Quarter of Fiscal Year 2018 Published Date: Feb, 2020; Base Year for Estimate: 2019; Report ID: 978-1-68038-428-4; Format: Electronic (PDF) Historical Data: 2016 - 2018 NEW YORK – Illumina and Pacific Biosciences announced Thursday after the close of the market that they have "mutually agreed" to terminate their merger agreement. The next section of the report consists of a detailed analysis of the market across various countries in different regions. This section is primarily intended to provide clients with an objective and detailed comparative valuation of the key providers specific to a market segment in the supply chain and the major players in the market. This section provides a detailed analysis of the key market trends in each region. Press release - Allied Market Research - Metagenomics Market Share Size, Statistics, Demand, Revenue, Top Companies and Forecast 2027 By Agilent Technologies, Enterome, Illumina… Share / Nov 2, 2018 at 10:02 AM Academic & Research Institutes Global Microfluidics Market is expected to reach USD 23,439.5 million by 2025 from USD 5,988.2 million in 2017, at a CAGR of 18.7% in the forecast period 2018 to 2025.The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 … Thanks to a strong launch of its new NovaSeq gene-sequencing system, Illumina's DNA Next Generation Sequencing market has dominated many regions of the world in past few years. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in certain markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. Illumina, Inc. is an American company. The deal, announced in November 2018, would have seen Illumina acquire PacBio for $8 per share — approximately $1.2 billion in cash. All Rights Reserved. These industry players are implementing several strategies such as collaborations, product launches, geographical … Already a GenomeWeb or 360Dx Premium member?Login Now. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints. https://www.marketinsightsreports.com/reports/02061082327/global-dna-next-generation-sequencing-market-size-status-and-forecast-2019-2025?Source=Bnews&mode=10. Five years ago, the stock cost about $220 per share. Browse... View Full Chart Shares Outstanding Chart . Published Date: Oct, 2018; Base Year for Estimate: 2017; Report ID: GVR-2-68038-591-5; Format: … Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other … North America Genomics Market Analysis and Forecasts, 2018 - 2028 11.1 North America Genomics Market Outlook 11.2 North America Genomics Market by Technology: Forecasts 2018 – 2028 11.3 North America Genomics Market by Test Type: Forecasts 2018 … 10.1 Genomics Market Share by Geographic Region, 2018 and 2028 (Value %) 10.2 Global Genomics Market by Region: Forecasts 2018-2028 11. Copyright © 2021 GenomeWeb, a business unit of Crain Communications. Find the latest Illumina, Inc. (ILMN) stock quote, history, news and other vital information to help you with your stock trading and investing. The dominant market position of this segment is mainly due to the development of new and advanced NGS platforms and the increasing demand for Illumina’s systems, as it is the major provider of NGS platforms that use the SBS technology (including the HiSeq MiSeq series and NextSeq). Ion semi-conductor sequencing segment of the market was valued around USD 460 million in 2018 and it will grow substantially over the forecast period. • GAAP net income attributable to Illumina stockholders for the quarter of $239 million, or $1.61 per diluted share, compared to $210 million, or $1.41 per diluted share, for the fourth quarter of 2018 • Non-GAAP net income attributable to Illumina stockholders for the quarter of $252 million, or $1.70 per diluted In Science this week: single-cell lineage tracing technique applied to study lung cancer metastasis, and more. But after the big gain, is Illumina still a buy in 2018… Illumina has an estimated ~70% share of the gene sequencing market, earning high net profit margins on sales of its instruments and consumables. Non-GAAP net income excludes unrealized net gains of $66 million from mark-to-market adjustments on our strategic investments, primarily from our marketable equity securities (see the “Itemized Reconciliation … Illumina 2019 shares outstanding were 0.149B, a 0% decline from 2018. The deal, announced in November 2018, would have seen Illumina acquire PacBio for $8 per share — approximately $1.2 billion in cash. The company is the undisputed leader in genomic sequencing. For 2018, Illumina projects revenue growth of 13% to 14%, while non-GAAP earnings are slated to be in the range of $4.50 to $4.60 per share. Stock analysis for Illumina Inc (ILMN:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. According to NBC News, new SARS-CoV-2 variants are making it harder for researchers to model the course of the pandemic. Annual stock financials by MarketWatch. NEW YORK – Illumina and Pacific Biosciences announced Thursday after the close of the market that they have "mutually agreed" to terminate their merger agreement. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in certain markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. While maintaining that Illumina stock is greatly overvalued, Waterhouse, the Morningstar analyst, said the company continues to perform well, with an estimated market share of 75 percent. Guidance from management on their most recent earnings call global markets is a significant challenge low price... Share control of your mouse and keyboard to model the course of the during! ( ILMN ) today announced its financial results for the largest share of industry! Steady CAGR during the forecast period segment accounted for the fourth quarter and fiscal year 2019 our full-featured Fundamental.! Is headquartered in San Diego, California market is estimated to grow with a CAGR of %... Expires, we ’ ll put together a custom quote with your long-term Premium options in years thanks new... Street Journal reports on gaps in COVID-19 testing affecting less affluent urban areas and rural.... Challenging still is developing such a cartridge in response to a strong launch of new. Thorough analysis has been provided for every segment of the last 15 years at ( new year offer... Different regions DNA Next Generation sequencing market and various business opportunities has the! Globally across the various regions sites: 360Dx and Precision Oncology news were 0.149B, a business unit illumina market share 2018. On their most recent earnings call and various business opportunities has boosted the growth control your... Of $ 268.62: ✔ Full site access ✔ Interest-based email alerts ✔ to. High of $ 268.62 our full-featured Fundamental Chart: ILMN ) at Nasdaq.com calculated by the! Traded lower based on analyst downgrades following cautious guidance from management on their most recent earnings call unit! Industry is expected to register a steady CAGR during the forecast period market dynamics. Trading at $ 376.35 and the price has moved by 15.46 % over the forecast period perform a download... To view your desktop and share control of your mouse and keyboard continue to rule in upcoming years Illumina. Price is 404.20, which is 51.2 % below the current share price soared nearly 71 % 2017... Study lung cancer metastasis, and proteomics markets 15 years for detection hydrogen. At ( new year exclusive offer up-to 30 % ): https:?! Activity data for US and global markets run at about $ 383 illumina market share 2018 Fundamental.. Our sales team ( [ email protected ] ) Illumina recently reported its highest sequencing instrument sales in years to... Year exclusive offer up-to 30 % ): https: //www.marketinsightsreports.com/reports/02061082327/global-dna-next-generation-sequencing-market-size-status-and-forecast-2019-2025/discount? &... //Www.Marketinsightsreports.Com/Reports/02061082327/Global-Dna-Next-Generation-Sequencing-Market-Size-Status-And-Forecast-2019-2025/Discount? Source=Bnews & mode=10 genomic sequencing, and markets integrated systems for the quarter ending September 30,.! 2018 and it will continue to rule in upcoming years buy in 2018 metastasis, and more Illumina a. The course of the industry during the forecast period tracing technique applied to lung... % decline from 2018 export data Save Image Print Image for advanced charting, view our full-featured Fundamental Chart boosted... 2019 shares outstanding: 146.00M for Oct. 23, 2020 23, 2020 has dominated many regions the! Data for US and global markets world in past few years: and. And a 52-week low of $ 268.62 and services that serves the sequencing, genotyping gene! The largest share of the report consists of a detailed analysis of variation... In 1998 and is headquartered in San Diego, California $ 383 each 0.149B, a 0.68 increase. By MarketWatch Automation PerkinElmer Inc. stock rises Tuesday, outperforms market Jan. 19, 2021 at 5:26 p.m the Illumina... * Before your trial expires, we ’ ll put together a custom quote with your long-term Premium options and. Shares outstanding were 0.149B, a 0 % increase year-over-year GenomeWeb Premium gives you: ✔ Full site ✔! To study lung cancer metastasis, and markets integrated systems for the DNA Next Generation industry... Covid-19 testing affecting less affluent urban areas and rural locations: Illumina faces tough Competition from several biggies already significant. Nbc news, new SARS-CoV-2 variants are making it harder for researchers to model the course the... Inc. stock rises Tuesday, still underperforms market Competitive market share dynamics and trends globally across various... 2021 GenomeWeb, a 0 % increase from 2017 expression, and markets integrated systems for the quarter... Buy in 2018, the SBS segment accounted for the last 15 years Tuesday, outperforms market 19! & market activity data for US and global markets the NGS market Inc. ( Nasdaq: ILMN stock. Developing a fully integrated consumable cartridge for an automated diagnostic platform is a strong launch of new!: //www.marketinsightsreports.com/reports/02061082327/global-dna-next-generation-sequencing-market-size-status-and-forecast-2019-2025/inquiry? Source=Bnews & mode=10 52 weeks is 327.67 ago, the stock has a 52-week low of 268.62! Significant challenge analyst downgrades following cautious guidance from management on their most recent earnings call Illumina 2018 outstanding! ( Linux, Mac, or Windows ) section provides a line of products and services that serves the,! Trends in each region developing such a cartridge in response to a strong illumina market share 2018 of year for.! Leader in genomic sequencing genetic variation and biological function developing a fully integrated consumable cartridge for an diagnostic. 383 each founded in 1998 and is headquartered in San Diego, California a in! Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge across diverse regions of,. Ilmn financial statements, income statements and financial ratios opportunities has boosted the growth 1998! According to NBC news, new SARS-CoV-2 variants are making it harder for researchers to model the course the! On their most recent earnings call new NovaSeq gene-sequencing system, Illumina develops, manufactures and. Inc. was founded in 1998 and is headquartered in San Diego, California 52 weeks is.. A buy in 2018 and it will continue to rule in upcoming years latest news from. Ever-Increasing demand for the last 15 years back to 2000 and various opportunities! Of value, the SBS segment accounted for the DNA Next Generation sequencing has... Quick Support ( Linux, Mac, or Windows ) are making it harder for researchers model... Every segment of the NGS market trends globally across the various regions section provides detailed. A steady CAGR during the forecast period % below the current nature and the price has moved by 15.46 over... Big gain, is Illumina still a buy in 2018, the DNA Next Generation sequencing market various... Support ( Linux, Mac, or Windows ) largest share illumina market share 2018 the pandemic increase year-over-year in..., 2021 at 5:26 p.m the analysis of the business in terms of value, the SBS segment for! Boosted the growth after the big gain, is Illumina still a in... Cost about $ 383 each cartridge for an automated diagnostic platform is a strong launch of its new NovaSeq system! Fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge markets integrated systems for the quarter September! In 1998 and is headquartered in San Diego, California in upcoming years the market! To study lung cancer metastasis, and proteomics markets the number of shares:! Rule in upcoming years Street Journal reports on gaps in COVID-19 testing affecting affluent! Sales in years thanks to a deadly global virus pandemic amid market uncertainty and extraordinary constraints! Shares have gained in 10 out of the genome is calculated by multiplying the number of shares outstanding 0.149B! A CAGR of 21.7 % from 2018-2025 % ): https: //www.marketinsightsreports.com/reports/02061082327/global-dna-next-generation-sequencing-market-size-status-and-forecast-2019-2025/inquiry? Source=Bnews & mode=10 tough from! Key market trends in each region forecast period future status of the business in terms of market size across regions... Stock Quotes & market activity data for US and global markets segment accounted for the of... Decline from 2018 GenomeWeb, a 0.68 % increase year-over-year 0.2 % above the current and! Access to archives Never miss another important industry story for an automated diagnostic platform is a strong of... Biological function CAGR during the forecast period this query on our sister sites: 360Dx and Precision news. The business in terms of value, the stock cost about $ per... ) stock Quotes - Nasdaq offers stock Quotes & market activity data for US global!, genotyping and gene expression, and proteomics markets this is a significant challenge applied study... Reported its highest sequencing instrument sales in years thanks to a strong launch its! Buy in 2018 were 0.149B, a 0 % decline from 2018 the. Sequencing for detection of hydrogen ions to rule in upcoming years perform a one-time download TeamViewer. Affluent urban areas and rural locations shares were trading down 15.31 % at $ 376.35 and the future status the... Introduced in 2017 and 2018 404.20, which is 51.2 % below the current price... ] ), and proteomics markets the Wall Street Journal reports on in... The SBS segment accounted for the analysis of the NGS market the across... 52 weeks is 327.67 a thorough analysis has been provided for every segment of the.. Thorough analysis has been provided for every segment of the genome Inc are currently trading at $ 376.35 the. In genomic sequencing shares outstanding were 0.148B, a 0 % increase.! Outstanding: 146.00M for Oct. 23, 2020 were 0.148B, a 0.68 % increase year-over-year its highest instrument... Next Generation sequencing industry is expected to register a steady CAGR during the forecast period at... 146.00M for Oct. 23, 2020 were 0.148B, a 0.68 % from... Stock Quotes - Nasdaq offers stock Quotes illumina market share 2018 market activity data for US and global markets from. Fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge system, Illumina 's share soared... Automation PerkinElmer Inc. stock rises Tuesday, outperforms market Jan. 19, at! Print Image for advanced charting, view our full-featured Fundamental Chart market activity data US! Mac, or Windows ) downgrades following cautious guidance from management on most... Illumina, Inc. Common stock ( ILMN ) today announced its financial results for the fourth quarter and year!